Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filomena Mazzeo

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Frontiers in Oncology|October 29, 2025
A case report of malignant hypertension and multiorgan dysfunction during immunotherapy for gallbladder cancerCaroline Anthon, Hugo Pierret, Frederic Houssiau, et al.
Case Reports in Oncology|April 18, 2022
BRCA1 Mutation: An Insidious Enemy with Multiple Facets…Pierrick Godin, Francois P Duhoux, Filomena Mazzeo, et al.
Frontiers in Oncology|February 9, 2026
Correction: A case report of malignant hypertension and multiorgan dysfunction during immunotherapy for gallbladder cancerCaroline Anthon, Hugo Pierret, Frederic Houssiau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Prospective randomized study comparing docetaxel, estramustine, and prednisone with docetaxel and prednisone in metastatic hormone-refractory prostate cancerJean-Pascal Machiels, Filomena Mazzeo, Marylene Clausse, et al.
The Journal of Pathology. Clinical Research|May 13, 2024
Recurrent and novel fusions detected by targeted RNA sequencing as part of the diagnostic workflow of soft tissue and bone tumoursRafael Zago Baltazar, Sofie Claerhout, Sara Vander Borght, et al.
JTCVS Open|December 31, 2025
Outcome of patients with curative-intent treatment for primary pulmonary sarcoma: Results from an international multicenter retrospective studyStephane Collaud, Theresa Stork, Dagmar Adamkova, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 9, 2026
How should primary pulmonary sarcoma be staged? Results of an International Multicenter AnalysisTheresa Stork, Dagmar Adamkova, Clemens Aigner, et al.
Cancer|March 5, 2020
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma GroupLorenzo D'Ambrosio, Nathan Touati, Jean-Yves Blay, et al.
The New England Journal of Medicine|March 8, 2023
Nirogacestat, a γ-Secretase Inhibitor for Desmoid TumorsMrinal Gounder, Ravin Ratan, Thierry Alcindor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2022
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled TrialMrinal M Gounder, Albiruni Abdul Razak, Neeta Somaiah, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Frontiers in Oncology|October 29, 2025
A case report of malignant hypertension and multiorgan dysfunction during immunotherapy for gallbladder cancerCaroline Anthon, Hugo Pierret, Frederic Houssiau, et al.
Case Reports in Oncology|April 18, 2022
BRCA1 Mutation: An Insidious Enemy with Multiple Facets…Pierrick Godin, Francois P Duhoux, Filomena Mazzeo, et al.
Frontiers in Oncology|February 9, 2026
Correction: A case report of malignant hypertension and multiorgan dysfunction during immunotherapy for gallbladder cancerCaroline Anthon, Hugo Pierret, Frederic Houssiau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Prospective randomized study comparing docetaxel, estramustine, and prednisone with docetaxel and prednisone in metastatic hormone-refractory prostate cancerJean-Pascal Machiels, Filomena Mazzeo, Marylene Clausse, et al.
The Journal of Pathology. Clinical Research|May 13, 2024
Recurrent and novel fusions detected by targeted RNA sequencing as part of the diagnostic workflow of soft tissue and bone tumoursRafael Zago Baltazar, Sofie Claerhout, Sara Vander Borght, et al.
JTCVS Open|December 31, 2025
Outcome of patients with curative-intent treatment for primary pulmonary sarcoma: Results from an international multicenter retrospective studyStephane Collaud, Theresa Stork, Dagmar Adamkova, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 9, 2026
How should primary pulmonary sarcoma be staged? Results of an International Multicenter AnalysisTheresa Stork, Dagmar Adamkova, Clemens Aigner, et al.
Cancer|March 5, 2020
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma GroupLorenzo D'Ambrosio, Nathan Touati, Jean-Yves Blay, et al.
The New England Journal of Medicine|March 8, 2023
Nirogacestat, a γ-Secretase Inhibitor for Desmoid TumorsMrinal Gounder, Ravin Ratan, Thierry Alcindor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2022
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled TrialMrinal M Gounder, Albiruni Abdul Razak, Neeta Somaiah, et al.
Pageof 4